Clover Biopharmaceuticals
François Verdier serves as Head of Global Regulatory Affairs at Clover. He has more than 25 years in vaccines and biologics development and regulatory affairs. Prior to Clover, Dr. Verdier was the Global Franchise Head for Regulatory Affairs at Sanofi Pasteur where he led the global regulatory strategy for vaccine development, including efforts to accelerate the approval of their COVID-19 vaccines. He also helped lead cross-functional project teams to fast-track vaccine submission for authorization and drug registration in key markets.
Dr. Verdier earned his MBA from the ESSEC Business School, a doctorate in toxicology from Université Paris Cité, and a Pharm.D. from Université Lyon.
This person is not in any offices
Clover Biopharmaceuticals
2 followers
Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases.